Development
Genpact Limited
G
$43.13
$1.032.45%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.48B | 4.43B | 4.41B | 4.39B | 4.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.48B | 4.43B | 4.41B | 4.39B | 4.37B |
| Cost of Revenue | 2.91B | 2.88B | 2.86B | 2.86B | 2.83B |
| Gross Profit | 1.57B | 1.56B | 1.55B | 1.53B | 1.54B |
| SG&A Expenses | 915.78M | 904.30M | 906.00M | 909.67M | 930.48M |
| Depreciation & Amortization | 31.46M | 33.87M | 36.98M | 39.62M | 42.67M |
| Other Operating Expenses | -644.00K | -28.50M | -28.45M | -28.82M | -28.41M |
| Total Operating Expenses | 3.85B | 3.79B | 3.78B | 3.78B | 3.77B |
| Operating Income | 624.06M | 647.05M | 633.18M | 612.10M | 600.06M |
| Income Before Tax | 602.22M | 566.87M | 533.04M | 478.03M | 465.24M |
| Income Tax Expenses | -29.03M | 137.21M | 125.13M | 114.70M | 111.83M |
| Earnings from Continuing Operations | 631.26 | 429.66 | 407.91 | 363.33 | 353.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 631.26M | 429.66M | 407.91M | 363.33M | 353.40M |
| EBIT | 624.06M | 647.05M | 633.18M | 612.10M | 600.06M |
| EBITDA | 725.62M | 751.18M | 742.61M | 728.45M | 724.92M |
| EPS Basic | 3.47 | 2.35 | 2.22 | 1.98 | 1.92 |
| Normalized Basic EPS | 2.05 | 2.11 | 2.07 | 1.97 | 1.91 |
| EPS Diluted | 3.43 | 2.32 | 2.19 | 1.94 | 1.88 |
| Normalized Diluted EPS | 2.02 | 2.08 | 2.02 | 1.92 | 1.87 |
| Average Basic Shares Outstanding | 729.38M | 731.80M | 733.71M | 734.90M | 736.74M |
| Average Diluted Shares Outstanding | 740.57M | 744.74M | 748.34M | 750.38M | 752.35M |
| Dividend Per Share | 0.55 | 0.54 | 0.53 | 0.51 | 0.50 |
| Payout Ratio | 15.84% | 22.84% | 23.55% | 25.86% | 25.99% |